Beyond the Gut: thyroxine malabsorption, pharmacokinetics, and delivery
The Journal of Clinical Endocrinology & Metabolism · 2026
DOI: 10.1210/clinem/dgag024 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Lawrence Siu-Chun Law und 5 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Division, Department of Medicine, National University Hospital, Singapore 119074, Singapore. Hauptthemen laut MEDLINE: Thyroxine, Malabsorption Syndromes, Hypothyroidism. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
Refractory primary hypothyroidism is defined by persistently elevated thyroid-stimulating hormone despite supraphysiological oral levothyroxine dosing. The distinction between true malabsorption and pseudomalabsorption (nonadherence) is critical for management planning. In 2023, Quiroz-Aldave et al proposed a comprehensive framework for the evaluation and management of refractory primary hypothyroidism, while Liu et al provided an updated overview of both conventional and novel levothyroxine formulations. This mini-review synthesizes recent evidence published since 2023 and presents 2 illustrative cases managed within our clinical service. A PubMed search identified 41 relevant publications, including case reports, pharmacological studies, and clinical investigations. Case 1, a young woman with congenital hypothyroidism, demonstrated adequate intestinal absorption on a supervised levothyroxine absorption test, with subsequent findings supporting pseudomalabsorption. Recent studies have validated rapid absorption protocols (2-3 hours), offering feasible and cost-effective alternatives to conventional prolonged protocols. Case 2, a man with papillary thyroid carcinoma and end-stage renal failure, exhibited impaired gastrointestinal absorption confirmed by absorption testing. Management required escalation to parenteral therapy, with subcutaneous levothyroxine ultimately achieving biochemical stability. Importantly, no standardized absorption test exists for off-label intramuscular or subcutaneous administration; pharmacokinetic principles, particularly area under the curve calculations, may help estimate absorption readiness in these contexts. Emerging literature highlights gastrointestinal, surgical, and pharmacologic contributors to true malabsorption, as well as the superiority of liquid formulations in selected contexts. Subcutaneous administration is gaining interest as a tolerable, patient-friendly alternative to intramuscular dosing, although safety and pharmacokinetic validation of parenteral T4 remain necessary. Novel formulations under development may further optimize therapeutic options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology Division, Department of Medicine, National University Hospital, Singapore 119074, Singapore.
- Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
- Duke-NUS Medical School, Singapore 169857, Singapore.
- Department of Pharmacy, National University Hospital, Singapore 119074, Singapore.
- Department of Pharmacy and Pharmaceutical Sciences, Faculty of Science, National University of Singapore, Singapore 117559, Singapore.
ORCID-Profile: Lawrence Siu-Chun Law, Nicholas Wei Xiang Kuu, Melissa Hui Ting Leong, Elaine Ah Gi Lo, Siang Fei Yeoh, Samantha Peiling Yang
Zitieren
APA
Law, L. S., Kuu, N. W. X., Leong, M. H. T., Lo, E. A. G., Yeoh, S. F., & Yang, S. P. (2026). Beyond the Gut: thyroxine malabsorption, pharmacokinetics, and delivery. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag024
Vancouver
Law LS, Kuu NWX, Leong MHT, Lo EAG, Yeoh SF, Yang SP. Beyond the Gut: thyroxine malabsorption, pharmacokinetics, and delivery. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag024
BibTeX
@article{Law2026,
author = {Law, Lawrence Siu-Chun and Kuu, Nicholas Wei Xiang and Leong, Melissa Hui Ting and Lo, Elaine Ah Gi and Yeoh, Siang Fei and Yang, Samantha Peiling},
title = {Beyond the Gut: thyroxine malabsorption, pharmacokinetics, and delivery},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgag024}
}
EUVIMED